Holen Sie sich die Stockscreener-App
131.73
1.42%
1.84
Handel nachbörslich:
132.49
0.76
+0.58%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Abbott Laboratories Aktie (ABT) Neueste Nachrichten
Illinois quick hits: State representative under investigation; Abbott plans expansion - www.cities929.com
Cell Counting Market is expected to generate a revenue of USD 16.5 Billion by 2031, Globally, at 6.20% CAGR: Verified Market Research® - GlobeNewswire Inc.
Drug Delivery Device Market Future Business Opportunities - openPR.com
Leukemia Screening Market Overall Study Report 2025-2032 | - openPR.com
Insiders At Abbott Laboratories Sold US$3.3m In Stock, Alluding To Potential Weakness - Yahoo Finance
Lobbying Update: $50,000 of ABBOTT LABORATORIES lobbying was just disclosed - Nasdaq
Jim Cramer Applauds Abbott Laboratories (ABT): “A Tour de Force Quarter – Robert Ford Is Keeping the Miles White Legacy Alive” - Insider Monkey
Abbott Laboratories Invests $500M in U.S. Amidst Trade Uncertainties, Creating 300 New Jobs in Illinois and Dallas - Hoodline
Abbott Labs' Rally Is Well DeservedFade The Rally For Now - Seeking Alpha
Abbott Laboratories to invest $500M in manufacturing, add 200 jobs in Illinois - Chicago Sun-Times
Abbott expects a ‘few hundred million’ in tariff costs in 2025 - Manufacturing Dive
Abbott Laboratories (NYSE:ABT) Q1 2025 Earnings Call Transcript - MSN
Abbott's Q1 earnings in focus as analysts see path to beat amid business strength - MSN
Brazil Enteral Nutrition Market Overall Study Report 2025-2032 - openPR.com
Tariff-Resistant Abbott Laboratories on Track for New Highs - Investing.com
Abbott Laboratories’ Earnings Call Highlights Robust Growth - TipRanks
Abbott Laboratories Plans $500M Manufacturing, R&D Expansion In DFW and Chicago - Bisnow
Abbott Laboratories Adjusts Financial Outlook With Increased Price Target - Evrim Ağacı
Abbott Laboratories First Quarter 2025 Earnings: EPS Misses Expectations - simplywall.st
RBC Capital lifts Abbott Labs target to $145, maintains Outperform By Investing.com - Investing.com India
Abbott Labs stock target raised to $144 by Bernstein SocGen - Investing.com India
RBC Capital lifts Abbott Labs target to $145, maintains Outperform - Investing.com
UBS maintains Buy on Abbott Labs with $148 price target By Investing.com - Investing.com India
Abbott price target raised to $140 from $138 at Evercore ISI - Yahoo Finance
Abbott Labs (ABT) Stock: Earnings Beat with Strong MedTech Growth and $500M U.S. Investment - CoinCentral
UBS maintains Buy on Abbott Labs with $148 price target - Investing.com
These Analysts Boost Their Forecasts On Abbott Laboratories After Better-Than-Expected Earnings - Benzinga
Piper Sandler raises Abbott Labs target to $145, keeps Overweight By Investing.com - Investing.com India
Piper Sandler raises Abbott Labs target to $145, keeps Overweight - Investing.com
Citi Reaffirms Their Buy Rating on Abbott Laboratories (ABT) - The Globe and Mail
Demystifying Abbott Laboratories: Insights From 11 Analyst Reviews - Benzinga
RBC Capital Increases Price Target for Abbott (ABT) to $145 | ABT Stock News - GuruFocus
Stifel cuts Abbott Labs stock target to $135, maintains buy rating - Investing.com India
Abbott Laboratories: Strong Performance and Strategic Positioning Drive Buy Rating - TipRanks
Oppenheimer Increases Price Target for Abbott (ABT) to $140 | ABT Stock News - GuruFocus
Abbott Laboratories (ABT): Among the Innovative Healthcare Stocks to Watch in 2025 - Yahoo Finance
Bernstein Boosts Abbott (ABT) Price Target to $144 on Strong Performance | ABT Stock News - GuruFocus
BTIG Ups Abbott (ABT) Price Target After Impressive Q1 Earnings | ABT Stock News - GuruFocus
Abbott Laboratories: Strong Growth and Resilience Justify Buy Rating - TipRanks
Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT) and Blueprint Medicines (BPMC) - The Globe and Mail
Oppenheimer lifts Abbott Labs target to $140, maintains outperform By Investing.com - Investing.com India
Oppenheimer lifts Abbott Labs target to $140, maintains outperform - Investing.com
BTIG raises Abbott Labs stock price target to $145 - Investing.com
Raymond James raises Abbott Labs price target to $142 - Investing.com
Raymond James raises Abbott Labs price target to $142 By Investing.com - Investing.com UK
Street View: Abbott's effective management could help it triumph over tariffs - TradingView
Abbott Laboratories (ABT) Q1 2025 Earnings Call Highlights: Strong Growth in Medical Devices ... - Yahoo Finance
Abbott Laboratories (ABT) Q1 2025 Earnings Call Highlights: Strong Growth in Medical Devices and Nutrition Amidst Diagnostics Challenges - GuruFocus
Abbott Laboratories Reports Strong Q1 2025 Results - TipRanks
Abbott to Expand US Manufacturing as Tariffs Loom - MSN
Stocks to Watch: Nvidia, AMD, Abbott Laboratories, ASML - WSJ
Abbott Laboratories: Strong Buy Rating Amid Robust Financial Performance and Growth Potential - TipRanks
Is Abbott a Beacon of Hope in the Tariff Conflict? - Medical Device and Diagnostic industry
Wintrust Business Minute: Abbott Laboratories to spend $500 million on manufacturing facilities, including one in Illinois - WGN Radio 720
Stocks Sink After Nvidia Warning: TG Therapeutics, Abbott Labs, Loar In Focus - Investor's Business Daily
Nvidia, AMD, ASML, United, Tesla, Abbott Labs, Travelers, Interactive Brokers, and More Movers - Barron's
Hertz, Abbott Laboratories, and Interactive Brokers: Trending tickers - Yahoo Finance
Health Giant Makes A Bullish Move Despite Mixed Report - Investor's Business Daily
Abbott Q1: Flexible Supply Chain And Strong Growth In Medical Devices (NYSE:ABT) - Seeking Alpha
Is Abbott Laboratories (ABT) the Best Dividend Monarch to Invest in Now? - Insider Monkey
1.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):